Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pegfilgrastim, ATC L03AA13 für die Zeit 01.03.2025 - 28.02.2026 (zzgl. Verlängerungsoption 1x12 Monate)

Deadline:5 Jan 2027, 11:00

Contract award

Estimated value
€1
Duration
12 months
Bidders
Awarded bidders
Name
Price
1 4 U Pharma GmbH
101 Carefarm GmbH
Aaragon Pharma s.r.o.
Abacus Medicine A/S
ACA Müller ADAG Pharma AG
Accord Healthcare SLU vertreten durch die Accord Healthcare GmbH
Allomedic GmbH
Amgen GmbH
axicorp Pharma GmbH
Biocon Biologics Germany GmbH
CC Pharma GmbH
EurimPharm Arzneimittel GmbH
Hexal AG
kohlpharma GmbH
Mundipharma GmbH
Orifarm GmbH
Originalis B.V.
Paranova Pack A/S
Pfizer Pharma GmbH
axicorp Pharma B.V.
Bodensee Pharma GmbH
HAEMATO PHARM GmbH
INOPHA GmbH
medac Gesellschaft für klinische Spezialpräparate mbH
PB Pharma GmbH
Mercell Logo

Feel free to reach out!

Mercell is the leading European provider of e-tendering and procurement systems, and information between buyers and suppliers in the professional market.

We appreciate your input.

© Mercell Group 2026

Terms & Conditions and Privacy Notice

Mercell Group

  • Email: post@mercell.com
  • Phone: +47 21 01 88 00
  • Address: Askekroken 11, 0277 Oslo, Norway

Your privacy is important to us

We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.